HIV Infections: all 4,342 studies
Page 33 of 44. Open to participants first (242), then studies with results posted, then the rest; newest registration first within each.
- TMC125-C227: A Phase II Randomized, Active-Controlled, Open Label Trial to Investigate the Efficacy and Tolerability of TMC125 in HIV-1 Infected Subjects, Who Are PI-Naive and With Documented Genotypic Evidence of NNRTI Resistance From Previous NNRTI UseCompletedNCT00225303Phase 2
- Development of a Life Skills Intervention for Young Adolescents Perinatally-Infected With HIV and Their CaregiversTerminatedNCT00224900
- Combination of Efavirenz and Truvada - COMET StudyCompletedNCT00224458Phase 4
- Boosted Atazanavir and Truvada Given Once-Daily - BATON StudyCompletedNCT00224445Phase 4
- Managing MedicationsCompletedNCT00222716Not applicable
- Pravastatin and Protease Inhibitors in HIV-infected PatientsCompletedNCT00221754Phase 2
- Treatment of Chronic Hepatitis C With PEG Interferon alfa2a and Ribavirin in HIV-infected PatientsCompletedNCT00221650Phase 2
- Viral and Host Factors in the Transmission and Pathogenesis of HIVTerminatedNCT00219947
- Observational Study of Treated and Untreated Acute and Early HIV-1 InfectionCompletedNCT00219934
- Immunogenicity and Safety of 2 Schedules of ALVAC-HIV vCP1452 in Chronically HIV-Infected PatientsCompletedNCT00219362Phase 2
- An Educational HIV Pre-Test Counseling Video Program for Off Hours Testing in the ED: A Randomized Control TrialTerminatedNCT00218907Not applicable
- An Effective Alternative to the Standard Referral System for HIV Testing in the Emergency Department During Off Hour Tours: A Randomized TrialCompletedNCT00218881Not applicable
- Specialized Cognitive-Behavioral Counseling Intervention to Reduce HIV Transmission Risk Behavior in HIV-Infected MenCompletedNCT00218712Not applicable
- Pre-HIV Test Counseling Intervention to Reduce HIV Infection Risk Behavior in Men Who Are Not HIV InfectedCompletedNCT00218699Not applicable
- A Network Intervention for Prevention of HIV Infection in Chennai, India - 1WithdrawnNCT00218686Phase 2
- RCT of Russian IDU Peer Network HIV Prevention Intervention - 1CompletedNCT00218673Phase 3
- Cohort Study for Patients Using Fuzeon (Enfuvirtide)Status unknownNCT00216359
- A Randomized, Dose-ranging Study of Alferon LDO in Asymptomatic HIV+ SubjectsTerminatedNCT00215852Phase 2
- An Imaging Trial of the Distribution of Topical Gel in the Human Vagina: Assessment of Bare SpotsStatus unknownNCT00214812Phase 1
- An Imaging Trial of the Distribution of Topical Gel Formulations in the Human VaginaStatus unknownNCT00214747Phase 1
- Once Daily 3TC, Efavirenz and ddI for HIV InfectionStatus unknownNCT00214435Phase 4
- A Randomized, Controlled, Cross-Over Trial of Safety of Vaginal Use of Carraguard by HIV-Infected WomenCompletedNCT00213044Phase 1
- Supportive Therapy for Adherence to ART(STAART)CompletedNCT00212940Not applicable
- Optimizing Antiretroviral Therapy in HIV-Infected Children and AdolescentsTerminatedNCT00207948
- The Role of Naive T-Cells in HIV PathogenesisStatus unknownNCT00206531
- Evaluation of an Intervention on Adherence to Highly Active Antiretroviral Therapy (HAART) in HIV Infected AdultsTerminatedNCT00203853Not applicable
- Community Mobilization, Mobile Testing, Same-Day Results, and Post-Test Support for HIV in Sub-Saharan Africa and ThailandCompletedNCT00203749Phase 3
- Lactate Metabolism Study in HIV Infected PersonsCompletedNCT00202228Phase 4
- Characterization of the Adherence Threshold for HIV Suppression of a Kaletra-based RegimenCompletedNCT00200369
- Zidovudine / Lamivudine + Nevirapine Twice Daily, Versus Tenofovir + Lamivudine + Nevirapine Once Daily in ARV-Naive PatientsStatus unknownNCT00199979Phase 3
- Trial of Vitamins in HIV Progression and TransmissionCompletedNCT00197743Phase 3
- Botswana Pediatric Respiratory Disease and Bloodstream Infection StudyCompletedNCT00197691
- Multivitamin Dosage Regimens in the Prevention of Adverse Pregnancy Outcomes Among HIV-Positive WomenCompletedNCT00197678Phase 3
- Botswana Diarrheal Diseases StudyCompletedNCT00197652
- Pharmacokinetic Study of Indinavir Drug Levels When Boosted With Ritonavir in ThailandCompletedNCT00197639
- The Adult Antiretroviral Treatment and Resistance Study (Tshepo)CompletedNCT00197613Phase 3
- Prevention of Milk-Borne Transmission of HIV-1C in BotswanaCompletedNCT00197587Not applicable
- Partnership on Nutrition and HIV/AIDS Research in Tanzania: Exploratory Research Study on Selenium and HIV InfectionCompletedNCT00197561Phase 3
- Development of Resistance Mutations in Pregnant HIV-positive (+) Women Following Perinatal Antiretroviral Therapy in IsraelTerminatedNCT00197366
- Study Of Chemokine Coreceptor 5 (CCR5) Antagonist GW873140 In R5/X4-Tropic Treatment-Experienced HIV-Infected SubjectsTerminatedNCT00197197Phase 3
- HIV Immune and Virological Responses Following the Administration of IL-2 Either Alone or Combined to ALVAC-HIV 1433 and HIV Lipopeptides in Patients Treated Early With HAART During Primary InfectionTerminatedNCT00196651Phase 2
- Multicentric Trial Comparing Three Therapeutical Strategies in Patients With Acute Primary HIV InfectionTerminatedNCT00196638Phase 2/3
- Salvage Therapy With Amprenavir, Lopinavir and Ritonavir in HIV-infected Patients in Virological Failure.CompletedNCT00196625Phase 2
- Once Daily Antiretroviral Therapy in HIV Infected Adults Treated With HAARTCompletedNCT00196612Phase 3
- Pilot Study on Once Daily FTC, ddI, Efavirenz Combination in Antiretroviral Naive HIV Infected AdultsCompletedNCT00196599Phase 2
- Efficacy and Safety of Addition of IL-2 to Pegylated Interferon Alpha 2a and Ribavirin in HIV/HCV Coinfected PatientsCompletedNCT00196586Phase 2
- Study Evaluating Vaccine in Adults With HIVTerminatedNCT00195312Phase 1
- Study Evaluating Vaccine in Adults With HIVCompletedNCT00195234Phase 1
- Effect of Medication Diaries on Adherence to Highly Active Antiretroviral Drugs Among HIV-1 Infected Kenyan ChildrenCompletedNCT00194545Phase 2
- Herpes Simplex Virus Type 2 (HSV-2) Suppression to Prevent HIV TransmissionCompletedNCT00194519Phase 3
- A Randomised, Open-label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-emtricitabine or Abacavir-lamivudine: The STEAL StudyCompletedNCT00192634Phase 4
- A 48-Week, Randomised, Study to Describe the Pharmacokinetic Profile and Durability of Atazanavir-Saquinavir-Ritonavir Once Daily and Describe the Pharmacokinetic Profile of Saquinavir-Ritonavir Using Saquinavir 500mg Formulation: the ASK-500 StudyCompletedNCT00192608Not applicable
- Immunogenicity and Tolerance of Two Strategies of Anti-HAV Vaccination in HIV-infected PatientsCompletedNCT00190242Phase 3
- An Evaluation of Immunogenicity and Safety of Two Doses of MVA-nef vs. MVA-BN in HIV-1 Infected PatientsCompletedNCT00189930Phase 2
- Pilot Study Evaluating Interruption of Enfuvirtide (Fuzeon, T20) in Patients With Enfuvirtide ResistanceCompletedNCT00187551Phase 4
- Evaluate Tolerability of a Recombinant DNA HIV-1 Vaccine in Healthy AdultsCompletedNCT00187148Phase 1
- Evaluation of the Safety of a Polyvalent Virus in Healthy AdultsCompletedNCT00187044Phase 1
- Effectiveness of a Telephone Intervention Program in Improving Depression, Coping, and Family Functioning in HIV-Infected Individuals and CaregiversCompletedNCT00183781Phase 3
- Long Term Follow-Up of HIV Infected Patients Who Have Previously Participated in HIV Clinical TrialsCompletedNCT00183287
- Immune Response to a Therapeutic HIV Vaccine Followed by Treatment Interruption in Patients With Acute or Recent HIV InfectionCompletedNCT00183261Phase 2
- Comparative Pharmacokinetics (PK) Study of Efavirenz or Lopinavir/Ritonavir Between Older and Younger HIV-Infected AdultsCompletedNCT00179335
- Proton Magnetic Resonance Spectroscopy (1H MRS) in Evaluating the Bone Marrow, Muscle and Adipose Tissue on Normal and Human Immunodeficiency Virus Infected SubjectsStatus unknownNCT00172315
- Impact of HIV and Its Treatment on Reverse Cholesterol TransportCompletedNCT00168233
- IL-7 Receptor Polymorphisms and Immune Recovery With HAARTCompletedNCT00168207
- Nevirapine Resistance Study: Nevirapine Resistance Among HIV-Infected MothersCompletedNCT00164762
- Breastfeeding, Antiretroviral, and Nutrition StudyCompletedNCT00164736Phase 3
- Community Intervention Trial for Youth (CITY) StudyCompletedNCT00164580Phase 2/3
- HIP: HIV Intervention for ProvidersCompletedNCT00164398Phase 2
- Adolescent Impact: A Behavioral Intervention for Adolescents Living With HIV/AIDSCompletedNCT00164385Not applicable
- Associations, Outcomes and Genomics of GB Virus C, Hepatitis C Virus and Human Immunodeficiency Virus InfectionTerminatedNCT00164060
- Monitoring Highly Active Antiretroviral Therapy in HIV-infected Parents in ThailandCompletedNCT00162682Phase 3
- PI Vs. NNRTI Based Therapy for HIV Advanced DiseaseStatus unknownNCT00162643Phase 4
- An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV InfectionNo longer availableNCT00162227
- An Expanded Access Study of Oral Liquid Efavirenz in the Treatment of Children With HIV Infection: CanadaNo longer availableNCT00162188
- ATV/Ritonavir Nevirapine Interaction (USPAC)CompletedNCT00162149Phase 1
- Lopinavir/r Monotherapy as Maintenance Therapy After Long Term Viral SuppressionCompletedNCT00160849Phase 4
- Induction-maintenance of Lopinavir/r in HIV-infected SubjectsCompletedNCT00159224Phase 4
- Analysis of Genetic Factors Which May Influence the Course of HIV InfectionCompletedNCT00159068
- Study of Treatment of Antiretroviral-naive, HIV-1-Infected Patients Comparing Tenofovir Disoproxil Fumarate Administered in Combination With Lamivudine and Efavirenz vs. Stavudine, Lamivudine and Efavirenz.CompletedNCT00158821Phase 3
- Liver Transplantation in Patients With Hepatitis C Virus (HCV) and Human Immunodeficiency Virus (HIV) CoinfectionTerminatedNCT00158535Phase 2
- Randomised Controlled Trial Assessing the Impact of Genital Herpes Suppressive Therapy on HIV SheddingCompletedNCT00158509Phase 2
- Feasibility Study of a Once Daily Antiretroviral Regimen in Vietnam (ANRS 1210 VIETAR)CompletedNCT00158470Phase 3
- Simple Once Daily Triple Regimen Including Tenofovir, Emtricitabine and Efavirenz in HIV-1 Infected Patients (ANRS 1207)CompletedNCT00158457Phase 3
- Randomised Trial of Structured Treatment Interruption of HAART in HIV-Infected Adults in Abidjan (ANRS 1269 TRIVACAN)CompletedNCT00158405Phase 3
- The Effects of a Supervised Exercise Program on Self Efficacy of People Living With HIV/AIDS.CompletedNCT00157170Not applicable
- RHIV A Pilot Study Refractory or Intolerant to Highly Active Antiretroviral Therapy (HAART)WithdrawnNCT00157027Phase 1
- Cellulose Sulfate and HIV Transmission Among WomenTerminatedNCT00153777Phase 3
- Project MIX: Behavioral Intervention to Reduce Risk Among Substance-Using MSMCompletedNCT00153361Not applicable
- To Determine if Chromium Nicotinate Supplementation Will Improve Insulin Resistance in HIV Patients With Metabolic AbnormalitiesCompletedNCT00152893Phase 2
- The Switch Study: The Role of Lamivudine/Emtricitabine (3TC/FTC) in Antiretroviral RegimensCompletedNCT00152061Not applicable
- Effect of Pioglitazone on HIV-1 Related Lipoatrophy: a Randomized, Double Blind, Placebo-Controlled Trial in 130 PatientsTerminatedNCT00148850Phase 3
- Antibody Responses to Pneumococcal Vaccines Among HIV-infected Adults.CompletedNCT00148824Phase 2
- A Pharmacokinetic (PK) Study of a Combination of Indinavir, Ritonavir, and AmprenavirCompletedNCT00148785Phase 4
- Influence of Pravastatin on Carotid Artery Structure and Function in HIV-infected Patients Under Antiretroviral TherapyCompletedNCT00147797
- Toxicity Substudy of Evaluation of Subcutaneous Proleukin in a Randomised International Trial (ESPRIT): TOXIL-2 SubstudyTerminatedNCT00147355Phase 3
- A Study of Zidovudine/Lamivudine and Either Nevirapine or Nelfinavir for Reduction of Mother-to-child HIV Transmission During BreastfeedingCompletedNCT00146380Phase 2
- Bone Mineral Density (BMD) in HIV InfectionTerminatedNCT00146094Not applicable
- The Pharmacokinetic Study of Saquinavir New Tablet Formulation in HIV-infected Pregnant Women.CompletedNCT00145561Phase 1/2
- Safety Study of Tipranavir Co-administered With Low-dose Ritonavir (TPV/r) in Patients With Advanced HIV-1 Infection and Limited Treatment OptionsCompletedNCT00144287Phase 3
- An Open-label, Non-randomized, Single-arm Study to Investigate the Mechanism(s) by Which Nevirapine Increases Plasma HDL in HIV+ SubjectsCompletedNCT00144261Phase 4